Online Registration is Open!
Register by Friday, February 26 to Save Up to $500!
Printed from the IBC Life Sciences Web site on February 14, 2016 11:57 AM ET.
Page location: http://www.ibclifesciences.com/Bioconjugates/overview.xml
June 13-15, 2016
Parc 55 Hilton
San Francisco, CA
The leading conferences in genome editing, cell lines, protein therapeutics, and bioconjugation have come together to create a platform for research scientists, biologists, and bioengineers can discuss the latest breakthroughs, technologies, and discoveries.
Taking innovative ideas from inception to the clinic with the latest breakthroughs and conjugation strategies including ADCs, conjugated vaccines, nanoparticle conjugates, and many more.
With the latest insights and advances in conjugation strategies; IBC's Bioconjugates: From Targets to Therapeutics conference will deliver:
Hear what your peers had to say about the leading event in Bioconjugation:
"Great variety of bioconjugation modalities. I'm sure this sort of crosstalk will create new innovations." - Roger Pak, Pfizer
"An all-encompassing smorgasbord to provide a really comprehensive update on what is happening in the biologics space" - Catherine Hutchings, Principal Scientist, Antibody Discovery, Heptares Therapeutics
"This is an outstanding venue for bringing together experts in the field, vendors, scientists and other interested parties, and the collaborative and open environment has always been rewarding. This meeting is on my calendar every year!" - Gene Lee, Ph.D., Director, Protein and Cell Sciences, EMD Serono